News

PAREXEL International Corporation (NASDAQ:PRXL), a global biopharmaceutical services provider, announced that the Company has expanded its early phase drug development capabilities to provide biopharmaceutical companies with dedicated support for Proof of Concept studies.

PharmaPros, a technical consulting and solutions provider specializing in data and workflow management for clinical trials, announced that Paradigm Spine, a provider of non-fusion and fusion spinal implant solutions, has selected the company's automated trial management solution, Dataflow Manager, for its coflex IDE clinical study, and future studies in the Paradigm Spine pipeline.

CRF Inc. (CRF), a global provider of electronic Patient Reported Outcomes (ePRO) for the Life Science Industry, will be providing delegates at the Society for Clinical Data Management (SCDM) Annual Conference with 250 Windows Mobile hand-held PDAs.

CEO Chairman Jim Walker of Octagon Research Solutions, Inc., a provider of breakthrough software and services to the life sciences industry, announced that Octagon is partnering with the Clinical Data Standards Interchange Consortium (CDISC) to provide continuing education on electronic data standards to FDA reviewers.

The Clinical Data Interchange Standards Consortium (CDISC), announced that the Food and Drug Administration (FDA) selected CDISC, via a formal RFP process, to provide training to FDA reviewers of regulatory submissions.

Nextrials, Inc., a clinical research software and services company, announced the addition of chief technology officer, Robert Barr, and vice president of global sales and marketing, Michelle Dockhorn, to its executive staff.

Tripos, a provider of drug discovery informatics products and services, and Pharsight Corporation (NASDAQ: PHST), a provider of software, strategic, and regulatory services designed to optimize clinical drug development, announced they have entered into a definitive agreement for Pharsight to be acquired by Tripos for approximately $57 million in cash.

Exco InTouch (www.excointouch.com) a mobile messaging provider for the pharmaceutical industry, announces that it has partnered with US-headquartered MMG (www.mmgct.com/mmg) an international industry leader in patient enrollment for clinical trials to enhance the efficacy of patient recruitment and retention services for pharmaceutical sponsors.

QPS' clinical research unit, Bio-Kinetic Clinical Applications, announces a joint collaboration with Quintiles that creates an integrated Cardiac Safety Service for sponsors by incorporating clinical conduct, core ECG laboratory support, independent cardiologist and medical monitor oversight, pharmacokinetic and statistical analysis, and reporting of cardiac safety trials.

Phase Forward (NASDAQ: PFWD), a provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, a provider of fully Web-integrated interactive response technology (IRT), for $40 million in cash.

Rho, Inc., and the National Institutes of Health (NIH), is pleased to announce that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Rho a six-year, $38.9 million contract to provide biostatistical, data management, and safety services to the Immune Tolerance Network (ITN).

Health Market Science (King of Prussia, PA) is offering a new data-driven approach to site selection for clinical trials. With nine years experience under its belt with its physician masterfile and claims data

Biomedical Systems, a global provider of centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.

The Foundation for Improving Data Quality (FIDQ) recently held its first meeting in Washington, DC, to outline future efforts to refine methodologies that increase the precision of subjective endpoints used in clinical trials.

AmeriStart announced that it has signed a sales, marketing, and business development services contract with Factory CRO, a leading international clinical research organization that specializes in conducting medical device studies for FDA and EU approvals.